Research Paper Volume 16, Issue 3 pp 2679—2701
Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma
Figure 4. Correlation of CRGs expression with overall survival (A) and disease-free survival (B).